About Mark Lotter

Mark Lotter is the founder and CEO of Nuance Biotech, a company he established in January 2015 to build a platform for innovation in China. Nuance Biotech aims to bring innovative compounds to the Chinese market, focusing on oncology and immunology. The company has successfully raised three rounds of funding from investors like Matrix Partners and C-Bridge Capital. Prior to Nuance Biotech, Lotter co-founded NovaMed Pharmaceuticals in 2005, which was acquired by SciClone Pharmaceuticals in 2011.

Resources Pricing

Resources

Join freeJoin for free Free · no credit card

Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

AI-scored pitch deck
Matched investor list
Personalized outreach drafts

Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

All
Seed & Pre-Seed
Series A & B
Fintech
SaaS & Dev Tools
Consumer & Social
Marketplace & Frontier
Mistakes to Avoid
Checklist
How to Send
Design
Length
Order
Storytelling
Investor Q&A
One-Pager
Email Templates
Data Room
Investor Update
Term Sheet
SAFE vs Priced
Due Diligence
Timeline
Metrics
Valuation
Cap Table
Pipeline
Board
Objections
References
Closing
Bridge Round
Down Round
Secondary Sale
Investor Rejection
First Meeting
Second Meeting
Partner Meeting
Post-Mortem
Update Cadence
Angel Round
Option Pool Shuffle
Fundraise Pause
Vetting VCs
First 90 Days
First Board Meeting
Reference Calls
NDA Template
Bylaws Template

LibraryPitch Deck Examples

Slide-by-slide guide

Library
Articles
Pitch Decks
Videos
Shorts
Profiles
Visuals
Questions
Ask

LibraryArticles

•By Alejandro Cremades

Mark Lotter, Founder of Nuance Biotech

About Mark Lotter

Mark Lotter at a glance

More founders in Shanghai, China (44)

Browse related founder lists (4)